| Literature DB >> 25116973 |
Brooke Walls, Laura Jordan, Lisa Diaz, Richard Miller.
Abstract
The field of cutaneous oncology is exploding with innovative treatment options, specifically in the field of targeted therapy. These advances offer new hope to select patients with high risk skin cancers. Here we provide a two part series reviewing targeted therapy for non-melanoma skin cancer. We begin our discussion with basal cell carcinoma, moving beyond the first-in-class hedgehog inhibitors and highlighting promising clinical trials.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25116973
Source DB: PubMed Journal: J Drugs Dermatol ISSN: 1545-9616 Impact factor: 2.114